We observed that CEPT1 deletion did not impact the growth of HT-1080 xenograft tumors but rendered the tumors more susceptible to IKE treatment; consequently, CEPT1 knockout tumors treated with IKE exhibited reduced tumor growth compared to control tumors subjected to IKE treatment (Fig. 3K and 3L). Here, CEPT1 is linked to neoplasm.